Condition: Type 1 Diabetes · Hypoglycemia · Hyperglycaemia Due to Type 1 Diabetes Mellitus · Sponsor: University of Colorado, Denver
The objectives of this study are to examine how sex hormones (use of hormonal birth control, menstrual cycle phase) impact glycemic control among women with type 1 diabetes (T1D), and to test adjustments to insulin dosing and food intake to ameliorate cycle-related glycemic variability. A secondary aim is to examine how the menstrual cycle and use of hormonal birth control impact patient-reported outcomes and glycemic responses to physical activity.
This description comes directly from the study's public registry record.
JANET K SNELL-BERGEON, PhD, MPH · 3037246762 · Janet.Snell-Bergeon@cuanschutz.edu
Catherine Chartier-Logan, MPH · 3037247505 · Catherine.Chartier-Logan@cuanschutz.edu
Always discuss trial participation with your own doctor first.
| University of Colorado | Aurora, Colorado, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06297980